Monthly Archives: July 2012

Learning the Truth About Clinical Trials

clinical-trial-sanofi

There are currently over 60,000 clinical trials occurring in the United States. These programs not only allow patients to access potentially ground-breaking new therapies, but also help researchers collect valuable data. Many patients have concerns about the risk involved, despite the importance of clinical trials in the drug development process. Common misperceptions can deter patients from seeking out new approaches to treatment that can currently only be found in clinical trials. The Masonic Cancer Center Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , , ,

Pharmaceuticals Play a Key Role in Value-Based Care

Dan Leonard

By Dan Leonard, President, National Pharmaceutical Council Public and private sector health care stakeholders have been struggling with how best to achieve the triple aim of better care for individuals, improved health for populations, and slower cost growth. Figuring out the best health care delivery structures and approaches is a complex challenge with many variables and moving parts. That’s why there is a great deal of debate and research into what changes can support the Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

The Great Green Fleet

GreatGreenFleet

Last week the U.S. Navy took part in the 22-nation Pacific Rim training exercises off the coast of Hawaii. Different for the U.S. Navy in this year’s exercise was the fact that its warships and fighter jets were powered by a 50-50 blend of biofuel and petroleum-based fuels. It was the operational debut of drop-in advanced biofuels in the Navy ships and aircrafts and the demonstration proved the green-fuels blend to be safe and effective. Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , ,

The U.S. Government’s Position in ACLU v. Myriad Genetics

Hans Sauer BTN

Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property, comments on  the Department of Justice’s brief and oral argument in the Myriad “gene patent” case.  Read his guest collumn on IPWatchdog. I have often wondered why the DOJ showed up out of nowhere two years ago, and started pressing legal theories that are contrary to decades of U.S. government policy and established patent law, and that would potentially invalidate thousands of patents to DNA molecules, enzymes, Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

2 FIELDS 1 GOAL: Protecting the Integrity of Science and Sport

Track

In just over a week, the eyes of the world will fall on London as the city hosts the opening ceremonies for the 2012 Summer Olympics.  Millions of people from around the globe will watch in awe as the world’s greatest athletes enthrall and inspire us, remind us of our common humanity and showcase the triumph of the human spirit as these amazing athletes push the limits of their physical capabilities. Sadly, some competitors succumb Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,